ALZHEIMER’S PREVENTION EDUCATION: IF WE BUILD IT, WILL THEY COME? www.AlzU.org
R.S. Isaacson, N. Haynes, A. Seifan, D. Larsen, S. Christiansen, J.C. Berger, J.E. Safdieh, A.M. Lunde, A. Luo, M. Kramps, M. McInnis, C.N. Ochner
J Prev Alz Dis 2014;1(2):91-98
Background: Internet-based educational interventions may be useful for impacting knowledge and behavioral change. However, in AD prevention, little data exists about which educational tools work best in terms of learning and interest in participating in clinical trials.
Objectives: Primary: Assess effectiveness of interactive webinars vs. written blog-posts on AD prevention learning. Secondary: Evaluate the effect of AD prevention education on interest in participating in clinical trials; Assess usability of, and user perceptions about, an online AD education research platform; Classify target populations (demographics, learning needs, interests). Design: Observational Setting: Online Participants: Men/Women, aged 25+, recruited via facebook.com Intervention: Alzheimer’s Universe (www.AlzU.org) education research platform Measurements: Pre/post-test performance, self-reported Likert-scale ratings, completion rates
Results: Over two-weeks, 4268 visits were generated. 503 signed-up for a user account (11.8% join rate), 196 participated in the lessons (39.0%) and 100 completed all beta-testing steps (19.9%). Users randomized to webinar instruction about AD prevention and the stages of AD demonstrated significant increases (p=0.01) in pre vs. post-testing scores compared to blog-post intervention. Upon joining, 42% were interested in participating in a clinical trial in AD prevention. After completing all beta-test activities, interest increased to 86%. Users were primarily women and the largest category was children of AD patients. 66.3% joined to learn more about AD prevention, 65.3% to learn more about AD treatment.
Conclusions: Webinar-based education led to significant improvements in learning about AD prevention and the stages of AD. AlzU.org participation more than doubled interest in AD prevention clinical trial participation. Subjects were quickly and cost-effectively recruited, and highly satisfied with the AD education research platform. Based on these data, we will further refine AlzU.org prior to public launch and aim to study the effectiveness of 25 interactive webinar-based vs. blog-post style lessons on learning and patient outcomes, in a randomized, within-subjects design trial.
R.S. Isaacson ; N. Haynes ; A. Seifan ; D. Larsen ; S. Christiansen ; J.C. Berger ; J.E. Safdieh ; A.M. Lunde ; A. Luo ; M. Kramps ; M. McInnis ; C.N. Ochner(2014): ALZHEIMER’S PREVENTION EDUCATION: IF WE BUILD IT, WILL THEY COME? www.AlzU.org.The Journal of Prevention of Alzheimer’s Disease (JPAD).http://dx.doi.org/10.14283/jpad.2014.4